Delivery Order SPE2DB20D7061-SPE2DB25FSMF1

Award Date 2/18/25
Potential Completion Date 2/19/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,826.55 Firm Fixed Price Delivery Order is for the medical product "MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML", with an ultimate completion date of July 2, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,354.15 firm-fixed-price delivery order is for the medical product "MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML". The contract has a completion date of December 5, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML. The $1,217.72 fixed-price contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, to provide a comprehensive range of medical commodities, including pharmaceuticals and...
This contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,030.65 firm fixed-price order is for the medical product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, with a completion date of May 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $50,371.20, is a delivery order for the medical product "MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML". This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,812.14 Firm Fixed Price Delivery Order is for the medical product "MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML" and has a completion date of February 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,482.00 firm fixed-price delivery order is for MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,044.25, is for the delivery of the pharmaceutical product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML. The contract has a firm fixed price pricing type and an ultimate completion date of August 2, 2024. This appears to be a delivery order issued under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This is a $1,217.72 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product "MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML" with a completion date of May 10, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $214,832.94 firm fixed-price contract has an ultimate completion date of November 15, 2023. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
  • SPE2DB20D7061
    Indefinite Delivery Contract
  • SPE2DB20D7061-SPE2DB25FSMF1
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,367.48, is a delivery order for the medical product "MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML". The contract has an ultimate completion date of February 19, 2025 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not include a set-aside designation, indicating open competition.

Generated 5/20/25, 2:29 PM